Principal Financial Group Inc. trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,263,828 shares of the biopharmaceutical company’s stock after selling 49,068 shares during the period. Principal […]